ID: ALA3277269

Max Phase: Preclinical

Molecular Formula: C19H26ClNO2S

Molecular Weight: 331.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1OCC(O)CNCCSCc1ccccc1.Cl

Standard InChI:  InChI=1S/C19H25NO2S.ClH/c1-16-7-5-6-10-19(16)22-14-18(21)13-20-11-12-23-15-17-8-3-2-4-9-17;/h2-10,18,20-21H,11-15H2,1H3;1H

Standard InChI Key:  COWGZVVKJLJOAW-UHFFFAOYSA-N

Associated Targets(non-human)

Felis catus 3858 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.48Molecular Weight (Monoisotopic): 331.1606AlogP: 3.26#Rotatable Bonds: 10
Polar Surface Area: 41.49Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.22CX LogP: 3.75CX LogD: 1.94
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.66Np Likeness Score: -1.10

References

1. Tucker H, Coope JF..  (1978)  beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.,  21  (8): [PMID:29123] [10.1021/jm00206a010]

Source